Acute liver injury in patients on Dapagliflozin

Trial Identifier: D1690R00005
Sponsor: AstraZeneca
NCTID:: NCT02695095
Start Date: January 2017
Primary Completion Date: September 2020
Study Completion Date: November 2020
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Kingdom London, United Kingdom
United States of America, DE Wilmington, DE, United States of America
United States of America, Washington DC Washington DC, United States of America